Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC1456 Ck2-in-7
Novel CK2 inhibitor, targeting an allosteric pocket, exhibiting an IC50 of 3.4 μM against purified CK2α in combination with a favorable selectivity profile
More description
DCC1455 Ck2-in-4p
Novel potent CK2 inhibitor
More description
DCC1454 Ck2-in-3b
Potent, reversible, and ATP-competitive inhibitor of casein kinase-2 (CK2)
More description
DCC1453 Ck2-in-27
Novel selective allosteric modulator of the protein kinase CK2, inducing apoptosis and cell death in 786-O renal cell carcinoma cells (EC50 = 5 µM) and inhibiting STAT3 activation even more potently than the ATP-competitive drug candidate CX-4945
More description
DCC1452 Ck-2-68
Novel potent PfNDH2 inhibitor
More description
DCC1451 Ck2 Inhibitor Hy1
Novel CK2 inhibitor, showing potent CSC inhibitory effects in A549 cells
More description
DCC1450 Cjc-1295
Long-lasting stimulator of the production of growth hormone (GH) from the pituitary gland
More description
DCC1449 Cjc-1293 Tfa Salt
Stimulator of the production of growth hormone (GH) from the pituitary gland
More description
DCC1448 Cj-887 Sodium Salt
Novel inhibitor of STAT3 activation and dimerization through targeting the phosphotyrosine binding site within the SH2 domain
More description
DCC1447 Cj-3-60
Anti-HIF-1alpha agent, inhibiting HIF-1alpha and cellular VEGF proteins
More description
DCC1446 Cj2-150
Novel non-ATP competitive allosteric inhibitor of Aurora B kinase, binding in the allosteric site F
More description
DCC1445 Cj-21058
SecA inhibitor, showing antiprotozoal, antibacterial and antifungal effects, inhibiting post-translational protein transport into the endoplasmic reticulum. also Inhibiting ATP-dependant translocation of precursor proteins acrossing a bacterial cell membr
More description
DCC1444 Cj2100
Novel potent muscarinic antagonist wirh antimuscarinic antidepressant-like activities, showing modest affinity across the mAChRs when compared to L-687306 and scopolamine
More description
DCC1443 Cj-1882
Potent and competitive antagonist at the human D3 receptor
More description
DCC1442 Cj-15208
Biological Active Reagents
More description
DCC1441 Cj-1383
Novel Cell-Permeable STAT3 Inhibitor, targeting the SH2 domain
More description
DCC1440 Cj-054
Polo-like kinase 1 (Plk1) inhibitor
More description
DCC1439 Cis-vz185
Negative control for VZ185
More description
DCC1438 Cis-cinnamic Acid
Novel, natural auxin efflux inhibitor, promoting lateral root formation
More description
DCC1437 Cis-4-d-hyp-d-ser Hydrochloride
JBP923 analog, exerting potent therapeutic effect on inflammatory bowel disease (IBD)
More description
DCC1436 Cis-3-4-dihydrohamacanthin B
Potent inhibitor of MRSA PK
More description
DCC1435 Cis,cis-2,6-dimethylcyclohexanol
Positive modulator of GABA A receptors
More description
DCC1434 Ciraparantag Acetate
Non-Specific Anticoagulant Reversal Agent
More description
DCC1433 Ciprofloxacin Hydrochloride Hydrate
Broad-spectrum antimicrobial carboxyfluoroquinoline, interfering with the bacterial DNA gyrase, inhibiting the DNA synthesis, and preventing bacterial cell growth
More description
DCC1432 Cinromide
Novel modulator of SLC6A19, robustly, selectively, and reproducibly inhibiting SLC6A19
More description
DCC1431 Cinitapride Tartrate
Agonist of the 5-HT1 and 5-HT4 receptors and as an antagonist of the 5-HT2 receptors
More description
DCC1430 cinanserin
5-HT2 antagonist
More description
DCC1429 Cimaterol
ß-Adrenergic agonist
More description
DCC1428 Cilofungin
Noncompetitive inhibitor of Candida albicans growth and activity of (1-3)-beta-glucan synthase
More description
DCC1427 Ci-ip3/pm
Cell permeable caged inositol triphosphate, promoting Ca2+-release from internal stores under UV photolysis
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X